(1) School of Mathematics, University of Southampton, SO17 1BJ Southampton, UK;(2) HIV/AIDS, Tuberculosis and Malaria cluster, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland
Abstract:
Background
The HIV epidemic has caused a dramatic increase in tuberculosis (TB) in East and southern Africa. Several strategies have the potential to reduce the burden of TB in high HIV prevalence settings, and cost and cost-effectiveness analyses can help to prioritize them when budget constraints exist. However, published cost and cost-effectiveness studies are limited.
